infliximab

infliximab (INFLECTRA) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Current US regulatory status: approved.

INFLECTRA is a marketed brand name for infliximab. Check FDA Drugs@FDA for the current US label holder and prescribing information.

infliximab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.